Improving access to capital, talent a priority for Boulder biotech firms

BOULDER — As Boulder Valley’s biotechnology and life sciences industry matures, it is becoming increasingly important for growing firms in the sector to gain better access to capital and talent.

Despite the region’s earned reputation as an innovation hotbed, Colorado’s distance from the major capital centers on the coasts presents a challenge for firms trying to raise money, industry leaders said during BizWest’s Life Sciences CEO Roundtable held Tuesday at the University of Colorado.

MBio Diagnostics Inc. CEO Christopher Myatt said it is important for local companies that find success to recirculate capital back into the…